The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
|
Activity Number:
|
554
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Wednesday, August 1, 2012 : 2:00 PM to 3:50 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #305566 |
|
Title:
|
Experimental Design for In Vitro Drug Combination Studies
|
|
Author(s):
|
Gregory Hather*+ and Huaihou Chen and Ray Liu
|
|
Companies:
|
Millennium: The Takeda Oncology Company and Columbia University and Millennium: The Takeda Oncology Company
|
|
Address:
|
35 Landsdowne Street, Cambridge, MA, , USA
|
|
Keywords:
|
drug combinations ;
experimental design ;
cell viability ;
synergy
|
|
Abstract:
|
In vitro drug combination studies typically involve a large number of wells with various concentrations of two drugs added together. To gain the most information from an experiment, what should the drug concentrations be? Here, we consider the case where the single drug response curves are known beforehand, but no previous data is available from the combination. We consider several designs, including C and D-optimal designs, and a factorial design. We evaluate these designs based on the expected variance of the synergy score for a large set of in vitro experiments performed at Millennium. Based on the results, we were able to identify which design was the most efficient and robust.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.